Vivalis and Kaketsuken Extend their Collaboration in the Tetsing of Vivalis EBx(R) Cells

Published: Jan 29, 2008

NANTES, FRANCE and KUMAMOTO, JAPAN--(Marketwire - January 29, 2008) - VIVALIS AND KAKETSUKEN EXTEND THEIR COLLABORATION IN THE TESTING OF VIVALIS EBx® CELLS FOR THE PRODUCTION OF HUMAN AND VETERINARY VIRAL VACCINE. VIVALIS and THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE (KAKETSUKEN) announced today that they have extended the research licence to 2 new viruses, one in the field of human disease, the other in the veterinary field.

Back to news